Claims
- 1. A composition, stabilized against discoloration, which comprises
- (a) a saturated polyolefin or mixture thereof,
- (b) a stabilizing amount of an alkaline metal salt of a fatty acid, or mixture thereof,
- (c) a stabilizing amount of a phenolic antioxidant, or mixture thereof, selected from the group consisting of
- n-octadecyl 3,5-di-tert-butyl-4-hydroxyhydrocinnamate, neopentanetetrayl tetrakis(3,5-di-tert-butyl-4-hydroxyhydrocinnamate), di-n-octadecyl 3,5-di-tert-butyl-4-hydroxybenzylphosphonate, 1,3,5-tris(3,5-di-tert-butyl-4-hydroxybenzyl)isocyanurate, thiodiethylene bis(3,5-di-tert-butyl-4-hydroxyhydrocinnamate), 1,3,5-trimethyl-2,4-6-tris(3,5-di-tert-butyl-4-hydroxybenzyl)benzene, 3,6-di-oxaoctamethylene bis(3-methyl-5-tert-butyl-4-hydroxyhydrocinnamate), 2,6-di-tert-butyl-p-cresol, 2,2'-ethylidene-bis(4,6-di-tert-butylphenol), 1,3,5-tris(2,6-dimethyl-4-tert-butyl-3-hydroxybenzyl)isocyanurate, 1,1,3-tris-(2-methyl-4-hydroxy-5-tert-butylphenyl)butane, 1,3,5-tris-[2-(3,5-di-tert-butyl-4-hydroxyhydrocinnamoyloxy)-ethyl]isocyanurate, 3,5-di-(3,5-di-tert-butyl-4-hydroxybenzyl)mesitol, hexamethylene bis(3,5-di-tert-butyl-4-hydroxyhydrocinnamate), 1-(3,5-di-tert-butyl-4-hydroxyanilino)-3,5-di(octylthio)-s-triazine, N,N'-hexamethylene-bis(3,5-di-tert-butyl-4-hydroxyhydrocinnamamide), calcium bis(ethyl 3,5-di-tert-butyl-4-hydroxybenzylphosphonate), ethylene bis[3,3-di(3-tert-butyl-4-hydroxyphenyl)butyrate], octyl 3,5-di-tert-butyl-4-hydroxybenzylmercaptoacetate, bis(3,5-di-tert-butyl-4-hydroxyhydrocinnamoyl)hydrazide, and N,N'-bis[2-(3,5-tert-butyl-4-hydroxyhydroxocinnamoyloxy)ethyl]oxamide, and
- (d) a stabilizing amount of a hydroxylamine derivative, or mixture thereof, of formula II to XIV ##STR14## wherein R is hydrogen or methyl,
- n is 1 or 2,
- R.sub.1 is hydroxyl,
- when n is 1,
- R.sub.2 is hydrogen, C.sub.1 -C.sub.18 alkyl optionally interrupted by one or more oxygen atoms, cyanoethyl, benzyl, glycidyl, a monovalent acyl radical of an aliphatic, cycloaliphatic, araliphatic or aromatic carboxylic acid, or of carbamic acid or of a phosphorus-containing acid, or a monovalent silyl radical, or
- when n is 2,
- R.sub.2 is C.sub.1 -C.sub.12 alkylene, C.sub.4 -C.sub.12 alkenylene, xylylene, a divalent acyl radical of an aliphatic, cycloaliphatic, araliphatic or aromatic dicarboxylic acid, of a dicarbamic acid or of a phosphorus-containing acid, or a divalent silyl radical;
- p is 1,2 or 3,
- R.sub.3 is hydrogen, C.sub.1 -C.sub.12 alkyl, C.sub.5 -C.sub.7 cycloalkyl, C.sub.7 -C.sub.8 aralkyl, C.sub.2 -C.sub.18 alkanoyl, C.sub.3 -C.sub.5 alkenoyl or benzoyl;
- when p is 1,
- R.sub.4 is hydrogen, C.sub.1 -C.sub.18 alkyl, C.sub.5 -C.sub.7 cycloalkyl, C.sub.2 -C.sub.8 alkenyl unsubstituted or substituted by a cyano, carbonyl or carbamide group, or it is glycidyl, a group of the formula --CH.sub.2 --CH(OH)--Z or of the formula --CONH--Z wherein Z is hydrogen, methyl or phenyl; or
- when p is 2,
- R.sub.4 is C.sub.2 -C.sub.12 alkylene, C.sub.6 -C.sub.12 arylene, xylylene, a --CH.sub.2 --CH(OH)--CH.sub.2 group, or a group --CH.sub.2 --CH(OH)--CH.sub.2 --O--X--O--CH.sub.2 --CH(OH)--CH.sub.2 -- wherein X is C.sub.2 -C.sub.10 alkylene, C.sub.6 -C.sub.15 arylene or C.sub.6 -C.sub.12 cycloalkylene; or, provided that R.sub.3 is not alkanoyl, alkenoyl or benzoyl, R.sub.4 can also be a divalent acyl radical of an aliphatic, cycloaliphatic or aromatic dicarboxylic acid or dicarbamic acid, or can be the group --CO--; or R.sub.3 and R.sub.4 together when p is 1 can be the cyclic acyl radical of an aliphatic or aromatic 1,2- or 1,3-dicarboxylic acid; or
- R.sub.4 is ##STR15## where T.sub.8 and T.sub.9 are independently hydrogen, alkyl of 1 to 18 carbon atoms, or T.sub.8 and T.sub.9 together are alkylene of 4 to 6 carbon atoms, or 3-oxapentamethylene,
- when p is 3,
- R.sub.4 is 2,4,6-triazinyl,
- when n is 1,
- R.sub.5 is C.sub.2 -C.sub.8 alkylene or hydroxylalkylene or C.sub.4 -C.sub.22 acyloxyalkylene; or
- when n is 2,
- R.sub.5 is (--CH.sub.2).sub.2 C(CH.sub.2 --).sub.2 ;
- R.sub.6 is hydrogen, C.sub.1 -C.sub.12 alkyl, allyl, benzyl, glycidyl or C.sub.2 -C.sub.6 alkoxyalkyl;
- when n is 1
- R.sub.7 is hydrogen, C.sub.1 -C.sub.12 alkyl, C.sub.3 -C.sub.5 alkenyl, C.sub.7 -C.sub.9 aralkyl, C.sub.5 -C.sub.7 cycloalkyl, C.sub.2 -C.sub.4 hydroxyalkyl, C.sub.2 -C.sub.6 alkoxyalkyl, C.sub.6 -C.sub.10 aryl, glycidyl, a group of the formula --(CH.sub.2).sub.m --COO--Q or of the formula --(CH.sub.2).sub.m --O--CO--Q wherein m is 1 or 2, and Q is C.sub.1 -C.sub.4 alkyl or phenyl; or
- when n is 2,
- R.sub.7 is C.sub.2 -C.sub.12 alkylene, C.sub.6 -C.sub.12 arylene, a group --CH.sub.2 CH(OH)--CH.sub.2 --O--X--O--CH.sub.2 --CH(OH)--CH.sub.2 -- wherein X is C.sub.2 -C.sub.10 alkylene, C.sub.6 -C.sub.15 arylene or C.sub.6 -C.sub.12 cycloalkylene, or a group --CH.sub.2 CH(OZ')CH.sub.2 --(OCH.sub.2 --CH(OZ')CH.sub.2).sub.2 -- wherein Z' is hydrogen, C.sub.1 -C.sub.18 alkyl, allyl, benzyl, C.sub.2 -C.sub.12 alkanoyl or benzoyl;
- Q.sub.1 is --N(R.sub.8)-- or --O--; E is C.sub.1 -C.sub.3 alkylene, the group --CH.sub.2 --CH(R.sub.9)--O-- wherein R.sub.9 is hydrogen, methyl or phenyl, the group --(CH.sub.2).sub.3 --NH-- or a direct bond;
- R.sub.10 is hydrogen or C.sub.1 -C.sub.18 alkyl, R.sub.8 is hydrogen, C.sub.1 -C.sub.18 alkyl, C.sub.5 -C.sub.7 cycloalkyl, C.sub.7 -C.sub.12 aralkyl, cyanoethyl, C.sub.6 -C.sub.10 aryl, the group --CH.sub.2 --CH(R.sub.9)--OH wherein R.sub.9 has the meaning defined above; a group of the formula ##STR16## or a group of the formula ##STR17## wherein G can be C.sub.2 -C.sub.6 alkylene or C.sub.6 -C.sub.12 arylene; or R.sub.8 is a group --E--CO--NH--CH.sub.2 --OR.sub.10 ;
- Formula VII denotes a recurring structural unit of a polymer where T.sub.3 is ethylene or 1,2-propylene, or is the repeating structural unit derived from an alpha-olefin copolymer with an alkyl acrylate or methacrylate; and where k is 2 to 100;
- T.sub.4 has the same meaning as R.sub.4 when p is 1 or 2,
- T.sub.5 is methyl,
- T.sub.6 is methyl or ethyl, or T.sub.5 and T.sub.6 together are tetramethylene or pentamethylene or mixture of said hydroxyamine derivatives;
- M and Y are independently methylene or carbonyl;
- L denotes straight or branched chain alkylene of 4 to 7 carbon atoms, 3-oxapentamethylene or 3-hydroxyazapentamethylene;
- T.sub.7 is the same as R.sub.7,
- T.sub.10 and T.sub.11 are independently alkylene of 2 to 12 carbon atoms, or T.sub.11 is ##STR18## T.sub.12 is ##STR19## where a, b and c are independently 2 or 3, and d is 0 or 1; and e is 3 or 4; and
- T.sub.13 is the same as R.sub.2 with the proviso that T.sub.13 cannot be hydrogen when n is 1.
- 2. A stabilized composition according to claim 1 which additionally contains
- (e) a stabilizing amount of a hindered amine light stabilizer, or mixture thereof, selected from the group consisting of bis(2,2,6,6-tetramethylpiperidin-4-yl)sebacate, bis(1,2,2,6,6-pentamethylpiperidin-4-yl)sebacate, di(1,2,2,6,6-pentamethylpiperidin-4-yl) (3,5-di-tert-butyl-4-hydroxybenzyl)-butylmalonate, tris(2,2,6,6-tetramethylpiperidin-4-yl) nitrilotriacetate, 1,2-bis(2,2,6,6-tetramethyl-3-oxopiperazin-4-yl)ethane, 2,2,4,4-tetramethyl-7-oxa-3,20-diaza-21-oxodispiro[5.1.11.2]-heneicosane, polycondensation product of 2,4-dichloro-6-tert-octylamino-s-triazine and 4,4'-hexamethylenebis(amino-2,2,6,6-tetramethylpiperidine), polycondensation product of 1-(2-hydroxyethyl)-2,2,6,6-tetramethyl-4-hydroxypiperidine and succinic acid, polycondensation product of 4,4'-hexamethylene-bis(amino-2,2,6,6-tetramethylpiperidine) and 1,2-dibromoethane, polycondensation product of 2,4-dichloro-6-morpholino-s-triazine and 4,4'-hexamethylenebis(amino-2,2,6,6-tetramethylpiperidine) N,N',N",N"'-tetrakis[(4,6-bis(butyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino)-s-triazin-2-yl]-1,10-di-amino-4,7-diazadecane, octamethylene bis(2,2,6,6-tetramethylpiperidin-4-carboxylate) and 4,4'-ethylenebis(2,2,6,6-tetramethylpiperazin-3-one).
- 3. A stabilized composition according to claim 1 which additionally contains
- (e) a stabilizing amount of an organic phosphorus compound, or mixture thereof, selected from the group consisting of tris(2,4-di-tert-butylphenyl)phosphite, 3,9-di(2,4-di-tert-butylphenoxy)-2,4,8,10-tetraoxa-3,9-di-phospha[5.5]undecane, tris(p-nonylphenyl)phosphite, 3,9-distearyloxy-2,4,8,10-tetraoxa-3,9-diphospha[5.5]-undecane, dilauryl phosphite, 3,9-di[2,6-di-tert-butyl-4-(2-n-octadecyloxycarbonyl)ethyl)-phenoxy]-2,4,8,10-tetraoxa-3,9-diphospha[5.5]undecane and tetrakis(2,4-di-tert-butylphenyl) 4,4'-bis(diphenylene)phosphonite.
- 4. A stabilized composition according to claim 2 which additionally contains
- (f) a stabilizing amount of an organic phosphorus compound, or mixture thereof, selected from the group consisting of tris(2,4-di-tert-butylphenyl)phosphite, 3,9-di(2,4-di-tert-butylphenoxy)-2,4,8,10-tetraoxa-3,9-diphospha[5.5]undecane, tris(p-nonylphenyl)phosphite, 3,9-distearyloxy-2,4,8,10-tetraoxa-3,9-diphospha[5.5]undecane, dilauryl phosphite, 3,9-di[2,6-di-tert-butyl-4-(2-(n-octadecyloxycarbonyl)ethyl)-phenoxy]-2,4,8,10-tetraoxa-3,9-di-phospha[5.5]undecane and tetrakis(2,4-di-tert-butylphenyl) 4,4'-bis(diphenylene)phosphonite.
- 5. A stabilized composition according to claim 1 which additionally contains
- (e) a stabilizing amount of a thiosynergist, or mixture thereof, selected from the group consisting of dilauryl thiodipropionate, distearyl thiodipropionate and neopentanetrayl tetrakis(3-dodecylthiopriopionate).
- 6. A stabilized composition according to claim 1 wherein the hydroxylamine derivative (d) is of formula II where n is 2, R is hydrogen, R.sub.1 is hydroxyl and R.sub.2 is sebacoyl; or of formula VIII where n is 1, T.sub.4 is n-octadecyl, M and Y are each carbonyl, and each of T.sub.5 and T.sub.6 together are pentamethylene.
- 7. A stabilized composition according to claim 1 wherein the hydroxylamine derivative (d) is of formula II where n is 1, R is hydrogen, R.sub.1 is hydroxyl and R.sub.2 is hydroxyl; or of formula VIII where n is 2, M is carbonyl, Y is methylene, T.sub.5 and T.sub.6 are each methyl and T.sub.4 is ethylene.
- 8. A stabilized composition according to claim 1 wherein the hydroxylamine derivative (d) is bis-(1-hydroxy-2,2,6,6-tetramethylpiperidin-4-yl) n-butyl-(3,5-di-tert-butyl-4-hydroxylbenzyl)malonate.
- 9. A stabilized composition according to claim 1 wherein the hydroxylamine derivative (d) is N,N',N",N"'-tetrakis[4,6-bis-(butyl-(1-hydroxy-2,2,6,6-tetramethylpiperidin-4-yl)amino)-s-triazin-2-yl]-1,10-diamino-4,7-diazadecane.
- 10. A composition according to claim 1 wherein component (a) is a polyolefin which is a homopolymer or copolymer of an alpha-olefin.
- 11. A composition according to claim 10 wherein the polyolefin is selected from the group consisting of polypropylene, low density polyethylene, medium density polyethylene, high density polyethylene, linear low density polyethylene, poly(butene-1), ethylene/vinyl acetate copolymer, ethylene/propylene copolymer, and copolymers of ethylene or of propylene with other alpha-olefins.
- 12. A composition according to claim 11 wherein the polyolefin is polypropylene, high density polyethylene, ethylene/propylene copolymer or a copolymer of ethylene or of propylene with another alpha-olefin.
- 13. A composition according to claim 11 wherein the phenolic antioxidant is neopentanetetrayl tetrakis(3,5-di-tert-butyl-4-hydroxyhydrocinnamate), n-octadecyl 3,5-di-tert-butyl-4-hydroxyhydrocinnamate, 1,3,5-trimethyl-2,4,6-tris(3,5-di-tert-butyl-4-hydroxybenzyl)benzene, 1,3,5-tris-(3,5-di-tert-butyl-4-hydroxybenzyl)isocyanurate, 2,6-di-tert-butyl-p-cresol or 2,2'-ethylidene-bis(4,6-di-tert-butylphenol).
- 14. A composition according to claim 3 wherein the organic phosphorus compound is tris(2,4-di-tert-butylphenyl)phosphite.
- 15. A composition according to claim 2 wherein the hindered amine light stabilizer is bis(2,2,6,6-tetramethylpiperidin-4-yl)sebacate, the polycondensation product of 1-(2-hydroxyethyl)-2,2,6,6-tetramethyl-4-hydroxypiperidine and succinic acid, the polycondensation product of 2,4-dichloro-6-tert-octylamino-s-triazine and 4,4'-hexamethylenebis(amino-2,2,6,6-tetramethylpiperidine) or N,N',N",N"'-tetrakis[4,6-bis(butyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino)-s-triazin-2-yl]-1,10-diamino-4,7-diazadecane.
- 16. A composition according to claim 5 wherein the thiosynergist is dilauryl thiopropionate or distearyl thiodipropionate.
- 17. A composition according to claim 4 wherein additionally contains the organic phosphorus compound tris(2,4-di-tert-butylphenyl)phosphite.
- 18. A composition according to claim 4 wherein the alkaline metal salt is calcium stearate, zinc stearate, magnesium behenate, sodium ricinoleate or potassium palmitate.
- 19. A composition according to claim 18 wherein the alkaline metal salt is calcium stearate.
Parent Case Info
This is a divisional of application Ser. No. 633,549, filed on July 23, 1984, now U.S. Pat. No. 4,590,231, issued on May 20, 1986, which in turn is a continuation-in-part of application Ser. No. 540,732, filed on Oct. 11, 1983, now abandoned.
US Referenced Citations (11)
Foreign Referenced Citations (2)
Number |
Date |
Country |
54-69162 |
Jun 1979 |
JPX |
1316341 |
May 1973 |
GBX |
Non-Patent Literature Citations (1)
Entry |
D. M. Wiles, "Kinnetics of UV Stabilization in Polymers"--presented Jun. 22-27, 1980 at N.Y. State University at New Paltz, N.Y. |
Divisions (1)
|
Number |
Date |
Country |
Parent |
633549 |
Jul 1984 |
|
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
540732 |
Oct 1983 |
|